Kelly-Anne Bryan, RN

While you sleep, your brain's white matter is charging up like a battery Myelin, the insulation around your nerve fibers, has been considered a passive structural component that speeds up signals. A new hypothesis from @FScholkmann and colleagues proposes it's actually an energy storage system that fills up during sleep and powers your neurons throughout the day. The paper, published in Progress in Biophysics and Molecular Biology, presents a radical reimagining of what myelin does beyond speeding up electrical signals along nerves. What is myelin? Myelin is the fatty sheath that wraps around nerve fibers like insulation around electrical wires. It's produced by specialized cells called oligodendrocytes in the central nervous system and makes up about 40% of your brain's volume. Traditionally, myelin's job has been simple: speed up nerve signals and provide structural support. This new hypothesis suggests it does something far more dynamic. The proton capacitor hypothesis The researchers propose myelin functions as a proton capacitor, meaning it stores energy in the form of protons (hydrogen ions) that accumulate during sleep and get released during wakefulness to produce ATP, the cell's energy currency. Think of it like a rechargeable battery. During sleep, myelin charges up by accumulating protons. During wakefulness, those protons flow through ATP synthase enzymes embedded in myelin, generating the energy neurons need to function. The mechanism involves two abundant myelin proteins: Myelin basic protein (MBP) sits between myelin layers and contains amino acids (lysine, arginine, histidine) that can absorb and hold protons. It functions as the energy storage component. Proteolipid protein (PLP) spans the myelin membrane and contains serine and threonine amino acids that form efficient proton conductors, creating pathways for protons to flow from storage sites to ATP synthase. How the charging cycle works During sleep, your myelin is actively storing energy. Specialized molecules in myelin pump protons (think of them as tiny charged particles) into storage proteins, like filling up a battery. During this phase, no energy is being used, just stored. When you wake up, the system switches into discharge mode. Those stored protons flow through protein channels to enzymes that convert them into ATP, your cells' usable energy form. This ATP travels through tiny tunnels called gap junctions directly into nerve fibers, where it powers your brain's activity. The researchers calculated that the amount of protons a small cube of myelin can hold matches exactly what your brain would need during 8 hours of wakefulness. The storage capacity and the daily demand align. The molecular sleep switch A naturally occurring molecule called oleamide acts as the on/off switch for this system. Throughout your waking hours, oleamide gradually accumulates in your brain. When it reaches a certain level, it closes those gap junctions, the tunnels that deliver ATP from myelin to nerve fibers. Once the tunnels close, your neurons can't access the energy supply. Neural activity drops. You get sleepy. With the delivery system shut down, myelin switches from discharge mode to charging mode. While you sleep, oleamide slowly breaks down. When enough of it clears out, the gap junctions reopen, ATP starts flowing to neurons again, and you wake up. This explains why you can't just decide to stay awake indefinitely. As oleamide builds up during the day, it eventually forces the system offline whether you want it to or not. Sleep isn't optional, it's a programmed metabolic requirement driven by molecular accumulation. How myelin produces energy without the usual machinery Here's where it gets strange: myelin can make ATP (cellular energy) even though it doesn't contain the typical power plants that cells use to generate energy. Normally, structures called mitochondria produce nearly all of a cell's ATP. But myelin has very few, if any, complete mitochondria. So how does it make energy? The researchers propose that mitochondria send small cargo packages carrying energy-producing equipment to the myelin. These packages fuse with myelin membranes and drop off the machinery, allowing myelin to produce ATP on its own. Think of it like getting a portable generator delivered to a remote cabin. You don't need a full power plant on site, just the essential equipment to generate electricity locally. The bigger the battery, the less time spent charging The researchers examined 23 different mammal species and discovered something remarkable: animals with more white matter (the brain tissue that's 95% myelin) need less sleep. Here's the pattern: • Bats have tiny brains with minimal white matter and sleep 20 hours a day • Humans have moderate white matter and sleep 8 hours a day • Elephants have massive white matter and sleep just 3.5 hours a day The logic is straightforward. More myelin means greater energy storage capacity. With a bigger battery, you need less time plugged in to fully recharge. The pattern suggests that more myelin provides greater energy storage capacity, reducing the time needed to recharge. Less myelin means longer recharging periods are required. This relationship also appears within humans across the lifespan. White matter volume peaks between ages 30-50, the same period when sleep duration reaches its minimum. Both follow inverted U-shaped curves over the human lifespan. Even sex differences align: women have less white matter than men and require more sleep on average. Experimental support The hypothesis draws on experimental work showing: • Isolated myelin vesicles consume oxygen and synthesize ATP via oxidative phosphorylation • Myelin vesicles exposed to NADH retain an energy charge that's later used for ATP synthesis when ADP and phosphate are added • Longer exposure to NADH produces more ATP in subsequent phases • This matches the predicted two-phase system: charging during simulated sleep, discharge during simulated wakefulness Sleep deprivation studies show myelin thickness decreases when animals are kept awake, consistent with discharge without adequate recharging time. Marathon runners show notable reductions in myelin after intense physical activity, suggesting the energy reserves get depleted during sustained neural and physical exertion. Key takeaways: • Myelin may function as a proton battery, storing energy during sleep and releasing it during wakefulness • Two myelin proteins (MBP and PLP) form a coupled system: one stores protons, the other conducts them to ATP synthase • Sleep duration correlates with white matter volume across 23 mammalian species • Oleamide, a natural sleep inducer, closes the gap junctions that deliver ATP from myelin to axons • Myelin contains functional mitochondrial components delivered via mitochondrial-derived vesicles • The human brain requires approximately 8 hours to fully recharge myelin's proton storage capacity • Sleep deprivation leads to measurable myelin degradation Limitations and open questions This remains a hypothesis requiring direct experimental validation in living systems. The calculations provide plausibility but don't prove the mechanism operates as proposed. Key questions: • Can proton accumulation and discharge be measured directly in myelin during sleep/wake cycles? • Does blocking this proposed system prevent normal sleep function? • How does this mechanism integrate with other established functions of sleep? • Can therapeutic interventions targeting this system improve sleep quality or neurological function? The challenge is that protons moving between membrane-bound buffers without entering free solution is difficult to measure experimentally. Why this matters If validated, this hypothesis fundamentally reframes our understanding of sleep. Rather than viewing sleep as a period when the brain passively recovers, it positions sleep as an active metabolic phase when the brain's white matter systematically stores energy for the next waking period. It also elevates myelin from a passive structural element to an active metabolic organizer that administers energy distribution to neurons. The framework could explain why myelin disorders often involve fatigue and why conditions affecting white matter integrity produce cognitive deficits even when gray matter remains intact. The identification of oleamide as the molecular switch controlling this cycle points to a natural compound that's been overlooked as a potential sleep therapeutic despite decades of evidence. The convergence of structural data (protein composition and positioning), metabolic data (oxygen consumption and ATP synthesis in myelin), molecular data (oleamide and gap junctions), and cross-species data (white matter volume and sleep duration) creates a compelling case that myelin plays a previously unrecognized role in sleep energetics. Whether this represents the primary function of sleep or one component of a multi-system process remains to be determined. But the hypothesis provides testable predictions and a mechanistic framework for understanding the metabolic foundations of the sleep-wake cycle.

We've been calling it mitochondrial dysfunction for decades. Turns out that term is scientifically meaningless, and it's been holding back progress in understanding how mitochondria actually work. @MitoPsychoBio and colleagues published a perspective in Nature Metabolism arguing that the language mitochondrial scientists use fails to capture what mitochondria actually are: multifunctional organelles that dynamically recalibrate across dozens of independent activities depending on what cells need. The problem starts with oversimplification. Mitochondria get reduced to the powerhouse of the cell in introductory biology. That framing suggests a single primary job: make ATP. Reality is more complex. Mitochondria synthesize steroid hormones. They produce iron-sulfur clusters required for hundreds of proteins throughout the cell. They regulate innate immunity and antiviral responses. They control programmed cell death. They generate signaling molecules that reprogram nuclear gene expression. They can transfer between cells to rescue damaged tissue. Key insight: These aren't backup functions that kick in when energy production fails. They're simultaneous, independent, cell-type-specific roles that mitochondria perform constantly. Here's why the terminology matters: When researchers measure decreased ATP production and call it mitochondrial dysfunction, they're collapsing dozens of distinct mitochondrial activities into a binary working/broken framework. That creates problems: • A mitochondrion producing less ATP might be signaling rather than failing • Different mitochondrial activities can change independently • What looks dysfunctional in one context may be adaptive in another • Cell-type differences get lost when using generic terms The paper proposes a hierarchical terminology system with five levels: 1. Cell-dependent properties: Mitochondrial characteristics that vary by cell type. Neurons, muscle cells, and immune cells contain functionally distinct mitochondrial populations adapted to tissue-specific demands. 2. Molecular features: The structural and compositional elements. Membrane potential, protein composition, lipid content, mtDNA copy number, cristae architecture. 3. Activities: Specific biochemical processes. Oxygen consumption, ATP synthesis, reactive oxygen species production, calcium buffering, metabolite synthesis. 4. Functions: The biological purposes these activities serve. Energy provision, biosynthesis, signaling, quality control, cell death regulation. 5. Behaviors: Dynamic responses over time. Fusion, fission, movement, mitophagy, biogenesis, transfer between cells. The framework distinguishes what mitochondria are made of, what they do biochemically, why they do it biologically, and how they change over time. Example of how this improves precision: Old framing: This drug causes mitochondrial dysfunction. New framing: This drug decreases complex I activity, reducing ATP synthesis capacity while increasing superoxide production at complex III, without affecting calcium handling or steroid synthesis. The second version identifies which specific mitochondrial activities change and which remain intact. That matters for predicting side effects, understanding mechanisms, and designing interventions. The malleable nature of mitochondria creates additional complexity. Mitochondrial characteristics can shift within minutes to hours in response to nutrient availability, stress, or signaling molecules. These recalibrations are often reversible and physiologically appropriate. Calling a physiological recalibration dysfunction conflates adaptation with pathology. A muscle cell's mitochondria after endurance training look different from before training. Neither state is dysfunctional. They're optimized for different demands. The perspective argues this terminology shift will improve three outcomes: Teaching: Students learn mitochondria are multifaceted organelles rather than single-purpose powerhouses, building a more accurate mental model from the start. Research progress: Specific terminology forces specific measurements. Asking which mitochondrial activities change rather than whether mitochondria are dysfunctional leads to more mechanistic studies. Interdisciplinary collaboration: Clearer language helps researchers from different fields understand exactly what aspects of mitochondrial biology are relevant to their questions. The implications extend beyond semantics. How scientists conceptualize mitochondria shapes which questions get asked, which measurements get prioritized, and how findings get interpreted. Moving from function/dysfunction binary to multidimensional assessment requires more complex experimental designs. But that complexity better matches the biological reality. Mitochondria aren't failing when they recalibrate. They're responding. Understanding which specific activities change, in which cells, under which conditions, and with what biological purpose represents the path forward for mitochondrial science.